More stories

  • in

    Arsenal names Athletic Brewing as official nonalcoholic beer partner

    Athletic Brewing Company is teaming up with Arsenal, becoming the English soccer team’s first nonalcoholic beer partner.
    Arsenal will feature Athletic Brewing’s Run Wild IPA at Emirates Stadium for both men’s and women’s matches, and Athletic Brewing will launch a marketing campaign and a series of promotions in return.
    Sales of no- and low-alcoholic beer are rising in the U.K., surging 38% on match days this summer.

    Athletic Brewing Company is the official nonalcoholic beer partner of Arsenal F.C.
    Courtesy: Athletic Brewing Co.

    Athletic Brewing Company has scored a partnership with Arsenal, becoming the English soccer team’s first official nonalcoholic beer partner.
    Arsenal will feature Athletic Brewing’s Run Wild IPA at Emirates Stadium for both men’s and women’s matches, and Athletic Brewing will launch a marketing campaign and a series of promotions in return, according to a press release.

    Run Wild IPA is less than 0.5% alcohol by volume, or ABV.
    The deal represents an opportunity for America’s largest nonalcoholic brewery to expand in the U.K.

    Athletic Brewing Company is the official nonalcoholic beer partner of Arsenal F.C.
    Courtesy: Athletic Brewing Co.

    “Our international footprint is expanding, and alcohol moderation is sweeping the globe, specifically among the next generation of consumers,” Bill Shufelt, co-founder and CEO of Athletic, said in the release. “This partnership represents an exciting milestone in our journey to revolutionize the way the world drinks.”
    Sales of no- and low-alcoholic beer are rising in the U.K., surging 38% on match days this summer, and there are similar trends in the U.S. with off-premise sales of nonalcoholic beer up nearly 30% year to date, according to the release.
    Arsenal is the latest sports entity to embrace nonalcoholic beer. Guinness 0.0 is the official nonalcoholic beer partner of the Premier League, and Formula 1 promotes Heineken 0.0.
    “New partners like Athletic are vital in supporting our growth so we can continue to invest in our teams and compete for major trophies,” Arsenal’s Chief Commercial Officer Juliet Slot said in the release.

    Don’t miss these insights from CNBC PRO More

  • in

    Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare

    President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023.
    Chris Kleponis | Bloomberg | Getty Images

    Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.
    Good afternoon! The first round of Medicare drug price negotiations has come to an end – but we still don’t know the final prices that the U.S. government and pharmaceutical companies have agreed on. 

    Medicare will disclose the new negotiated prices for 10 drugs at the beginning of September. Those prices will then go into effect in 2026. 
    Still, drugmakers appear to be less concerned about the impact of those new negotiated prices on their businesses than in recent months, at least in the short term. They all maintain that Medicare drug price negotiations are a long-term threat to the pharmaceutical industry’s drug innovation and profits, but the immediate dust has somewhat settled. 
    That’s based on executive commentary during the recent quarterly earnings calls of Bristol Myers Squibb and Johnson & Johnson, among other companies. 
    President Joe Biden’s Inflation Reduction Act gave Medicare the power to directly hash out drug prices with manufacturers for the first time in the federal program’s nearly 60-year history. The process aims to make expensive medications more affordable for older Americans. 
    On July 26, Bristol Myers Squibb CEO Christopher Boerner confirmed that the company received the government’s final price for its blood thinner Eliquis, which it shares with Pfizer. 

    He said now that the company has seen that price, it is “increasingly confident in our ability to navigate the impact” of Medicare drug price negotiations on the treatment. Bristol Myers will provide more details about the expected impact on its investor relations website once Medicare publicly discloses the final prices, according to Boerner. 
    Meanwhile, AbbVie CEO Robert Michael said a day earlier that the drugmaker has included the expected sales hit to its top-selling leukemia drug, Imbruvica, in its financial forecasts. 
    “We’ve come out and said that even with modeling that impact in, that we still expect to deliver on our long-term outlook,” Michael said on the company’s earnings call. 
    On July 17, J&J Worldwide Chairman Jennifer Taubert similarly said the company’s long-term growth outlook “still looks very good to us today” after seeing the negotiated prices for its blood thinner Xarelto and psoriasis treatment Stelara. 
    Novartis CEO Vasant Narasimhan said on July 18 that the short-term impact from Medicare drug price negotiations “might be manageable on our first set of drugs.” The company’s heart failure drug, Entresto, is among those selected for negotiations. 
    But Narasimhan said the policy in the long-term is “really not good for innovation [or] good for patients” in the U.S.
    “I think it’s very important to say the policy is not a good one. It’s bad for American patients, it’s bad for innovation and [I] sincerely hope that it gets corrected,” he said. 
    Executives at each of the drugmakers similarly emphasized their opposition to Medicare drug price negotiations on their respective earnings calls. 
    “We continue to believe that arbitrary price setting by the government on life-saving medicines is not good public policy,” Bristol Myers Squibb’s Boerner said on the company’s earnings call. “Irrespective of short-term dynamics, we remain very concerned about the long-term implications of IRA on innovation.”
    Lawsuits brought by Merck and Novartis against the negotiations are awaiting decisions from district courts. Each case brings claims that overlap with suits from Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, J&J and industry trade groups that have been rejected in recent months. 
    Feel free to send any tips, suggestions, story ideas and data to Annika at annikakim.constantino@nbcuni.com.

    Latest in health-care technology

    Health care goes Hollywood (sort of)
    Lights, camera, action!
    If you’re like me, health care is probably not the first thing you associate with the entertainment industry. Unless, of course, we’re talking about the hit medical drama “Grey’s Anatomy.” 
    But Northwell Health, the largest health system in the state of New York, is breaking new ground in the entertainment world. In late July, it launched a TV and film production studio called Northwell Studios. 
    The goal is not to turn the studio into a money-making machine, said Ramon Soto, chief marketing officer at Northwell Health. The health system actually plans to ensure most projects remain cost neutral. 
    Instead, Soto said the studio was created to help raise awareness about Northwell, especially since it operates within a competitive and saturated market. The New York metropolitan area is teeming with prestigious health systems and academic medical centers, and it’s Soto’s job to cut through the noise. 
    Northwell has dabbled with entertainment projects in the past. It participated in the Netflix docu-drama series “Lenox Hill” as well as an Academy Award-shortlisted Covid-19 documentary and a documentary about mental health with HBO. 
    Soto said Northwell Studios is meant to help the health system carry out these kinds of projects more regularly. 
    “The intention behind Northwell Studios is not, ‘Hey, we’re going to show up, it’s showbiz and get our name in lights.’ It’s really to create a bit more of an infrastructure to do this on a regular basis,” Soto told CNBC in an interview. “I’m not building a soundstage, I’m not building a studio, but I have millions of square feet and 21 hospitals and 88,000 employees, caregivers, storytellers.”
    Soto said there are already five projects in development, though not all of them will necessarily come to completion. He said unscripted content has been Northwell’s “bread and butter” so far, and there’s an extensive consent process in place for the patients and employees who opt in. 
    Northwell Studios is also exploring opportunities to produce scripted content, but patients shouldn’t expect to see actors and camera crews running through the halls.
    “We’re a health system, we can’t disrupt our operations or patient flows,” Soto said. “We’ll figure out the least disruptive, most impactful way to capture this content.”
    Feel free to send any tips, suggestions, story ideas and data to Ashley at ashley.capoot@nbcuni.com. More

  • in

    Markets are counting on the Fed to head off recession with sizeable interest rate cuts

    In the market’s eyes, the Fed finds itself either poised to head off recession or doomed to repeat the mistakes of its recent past.
    “No recession today, but one is increasingly inevitable by year-end if the Fed fails to act,” said Steve Blitz, chief U.S. economist at TS Lombard.
    Traders are pricing in a half-point September cut, followed by aggressive easing that could lop 2.25 percentage points off the Fed’s short-term borrowing rate by the end of next year.

    Federal Reserve Chairman Jerome Powell takes a question from a reporter during a news conference following a Federal Open Market Committee meeting at the William McChesney Martin Jr. Federal Reserve Board Building on July 31, 2024 in Washington, DC. 
    Andrew Harnik | Getty Images

    In the market’s eyes, the Federal Reserve finds itself either poised to head off a recession or doomed to repeat the mistakes of its recent past — when it was too late seeing a coming storm.
    How Chair Jerome Powell and his cohorts at the central bank react likely will go a long way in determining how investors negotiate such a turbulent climate. Wall Street has been on a wild ride the past several days, with a relief rally Tuesday ameliorating some of the damage since recession fears intensified last week.

    “In sum, no recession today, but one is increasingly inevitable by year-end if the Fed fails to act,” Steven Blitz, chief U.S. economist at TS Lombard, said in a note to clients. “But they will, beginning with a [half percentage point] cut in September telegraphed in late August.”
    Blitz’s comments represent the widespread sentiment on Wall Street — little feeling that a recession is an inevitability unless, of course, the Fed fails to act. Then the probability ramps up.
    Disappointing economic data recently generated worries that the Fed missed an opportunity at its meeting last week to, if not cut rates outright, send a clearer signal that easing is on the way. It helped conjure up memories of the not-too-distant past when Fed officials dismissed the 2021 inflation surge as “transitory” and were pressed into what ultimately was a series of harsh rate hikes.
    Now, with a weak jobs report from July in hand and worries intensifying over a downturn, the investing community wants the Fed to take strong action before it misses the chance.
    Traders are pricing in a strong likelihood of that half-point September cut, followed by aggressive easing that could lop 2.25 percentage points off the Fed’s short-term borrowing rate by the end of next year, as judged by 30-day fed funds futures contracts. The Fed currently targets its key rate between 5.25%-5.5%.

    “The unfortunate reality is that a range of data confirm what the rise in the unemployment rate is now prominently signaling — the US economy is at best at risk of falling into a recession and at worst already has,” Citigroup economist Andrew Hollenhorst wrote. “Data over the next month is likely to confirm the continued slowdown, keeping a [half-point] cut in September likely and a potential intermeeting cut on the table.”

    Emergency cut unlikely

    With the economy still creating jobs and stock market averages near record highs, despite the recent sell-off, an emergency cut between now and the Sept. 17-18 open market committee seems a longshot to say the least.
    The fact that it’s even being talked about, though, indicates the depth of recession fears. In the past, the Fed has implemented just nine such cuts, and all have come amid extreme duress, according to Bank of America.
    “If the question is, ‘should the Fed consider an intermeeting cut now?’, we think history says, ‘no, not even close,'” said BofA economist Michael Gapen.
    Lacking a catalyst for an intermeeting cut, the Fed is nonetheless expected to cut rates almost as swiftly as it hiked from March 2022-July 2023. It could start the process later this month, when Powell delivers his expected keynote policy speech during the Fed’s annual retreat in Jackson Hole, Wyoming. Powell is already being expected to signal how the easing path will unfold.
    Joseph LaVorgna, chief U.S. economist at SMBC Nikko Securities, expects the Fed to cut rates 3 full percentage points by the end of 2025, more aggressive than the current market outlook.
    “Go big or go home. The Fed has clearly said that rates are too high. Why would they be slow at removing the tightness?” he said. “They’ll be quick in cutting if for no other reason than rates aren’t at the right level. Why wait?”
    LaVorgna, though, isn’t convinced the Fed is in a life-or-death battle against recession. However, he noted that “normalizing” the inverted yield curve, or getting longer-dated securities back to yielding more than their shorter-dated counterparts, will be an integral factor in avoiding an economic contraction.
    Over the weekend, Goldman Sachs drew some attention to when it raised its recession forecast, but only to 25% from 15%. That said, the bank did note that one reason it does not believe a recession is imminent is that the Fed has plenty of room to cut — 5.25 percentage points if necessary, not to mention the capacity to restart its bond-buying program known as quantitative easing.
    Still, any quakes in the data, such as Friday’s downside surprise to the nonfarm payrolls numbers, could ignite recession talk quickly.
    “The Fed is as behind the economic curve now as it was behind the inflation curve back in 2021-2022,” economist and strategist David Rosenberg, founder of Rosenberg Research, wrote Tuesday. He added that the heightened expectation for cuts “smacks of a true recession scenario because the Fed has rarely done this absent an official economic downturn — heading into one, already in one, or limping out of one.” More

  • in

    Disney raises streaming prices for Hulu, Disney+ and ESPN+

    Starting mid-October, most plans for Disney+, Hulu and ESPN+ will cost $1 to $2 more per month.
    The price hikes come as Disney continues to push its customers toward bundles to get a bigger bang for their buck.

    The atmosphere at the Disney Bundle Celebrating National Streaming Day at The Row in Los Angeles on May 19, 2022.
    Presley Ann | Getty Images Entertainment | Getty Images

    Disney is raising prices on its streaming platforms.
    Starting mid-October, most plans for Disney+, Hulu and ESPN+ will cost $1 to $2 more per month, according to a press release Tuesday. The most expensive plans for Hulu, which include live TV, will cost $6 more per month.

    Disney+ basic and premium will be priced at $9.99 and $15.99, respectively. Hulu with ads will cost $9.99 monthly, while Hulu without adds will cost $18.99 per month. ESPN+, which features ads, will cost $11.99 per month.
    The price hikes come as Disney continues to push its customers toward bundles to get a bigger bang for their buck.
    For some time, Disney has offered a bundle of its own services, either Hulu and Disney+, or the two streaming services plus ESPN+. The existing bundle of Disney+ and Hulu, with ads, will also get a price hike this fall, up $1 to $10.99 per month. The same bundle without ads won’t see any price increase from the current rate of $19.99 per month.
    Disney has also partnered with Warner Bros. Discovery to offer a bundle, which will include Disney+, Hulu and Max. In July, the companies announced the bundle would be available for $16.99 with ads, and $29.99 commercial free, noting “a savings of 38% compared with the price of the services purchased separately.”
    Disney also aims to entice subscribers with ABC News Live and a playlist featuring preschool content, available to all subscribers starting Sept. 4, according to the release Tuesday. The company plans to introduce four more curated playlists for premium subscribers.

    “Playlists are the latest example of how we’re providing the best value and experience for our subscribers every time they open Disney+,” Alisa Bowen, president of the streaming platform, said in the news release.
    Disney reports its fiscal third-quarter earnings before the bell on Wednesday.

    Don’t miss these insights from CNBC PRO More

  • in

    The stockmarket rout may not be over

    For a while on August 5th things were looking awful. During the Asian trading session Japan’s benchmark Topix share index had fallen by 12%, marking its worst day since 1987. Stock prices in South Korea and Taiwan had tanked by 9% and 8% respectively, and European markets were falling. Before trading began in America, the VIX index, which measures how wildly traders expect share prices to swing, was at a level it had only reached early in the covid-19 pandemic and after Lehman Brothers collapsed in 2008. Ominously, though gold is usually a hedge against chaos, its price was falling—suggesting that investors might be selling assets they would rather hold on to in order to stay afloat. The previous week’s rout in global markets seemed to be spiralling into a full-blown crisis. More

  • in

    Charles Barkley commits to staying at Warner Bros. Discovery’s TNT Sports no matter what happens to NBA

    Charles Barkley said in a statement Tuesday he is not retiring and will stay with TNT Sports.
    Barkley said in June he planned to retire after next year’s NBA season.
    Barkley signed a 10-year deal with TNT Sports in 2022.

    NBA analyst Charles Barkley talking on set before the New York Knicks game against the Cleveland Cavaliers at the then-Quicken Loans Arena in Cleveland, Ohio, on Oct. 25, 2016.
    David Dow | National Basketball Association | Getty Images

    Charles Barkley is not retiring and he is not leaving TNT Sports.
    The star broadcaster and National Basketball Association Hall of Famer said Tuesday that he plans to stay with Warner Bros. Discovery’s TNT Sports even if the company does not emerge with NBA media rights.

    “I’m looking forward to continuing to work with [TNT Sports] both on the shows we currently have and new ones we develop together in the future,” Barkley said in a statement. “This is the only place for me. I have to say … I’ve been impressed by the leadership team who is fighting hard and have been aggressive in adding new properties to TNT Sports, which I am very excited about. I appreciate them and all of my colleagues for their continued support, and most importantly our fans. I’m going to give my all as we keep them entertained for years to come.” 
    Barkley’s future has become hazy given the NBA’s potential move away from TNT after next season.
    Warner Bros. Discovery sued the NBA last month to forcibly invoke the company’s matching rights on a package of games earmarked to go to Amazon Prime Video as part of the league’s new media rights deal. The NBA rejected Warner Bros. Discovery’s match as invalid because the league claimed Amazon’s games are for a streaming-only service. While Warner Bros. Discovery would stream the games on Max, it would also air them on TNT.
    TNT Sports owns the media rights to numerous different sports, including Major League Baseball, the NCAA Men’s Basketball Championship, the National Hockey League and the United States Soccer Federation. Beginning next year, the company will add NASCAR, The French Open and more than 65 regular-season Big East basketball games.
    Warner Bros. Discovery will be the home of some college football playoff games beginning this year. Barkley will play a role in the coverage of some of the events.

    “It’s fantastic to have Charles for this journey as we develop new content ideas and shows for our fans,” TNT Sports Chairman and CEO Luis Silberwasser said in a statement.
    Barkley is one of the stars of the popular NBA studio show “Inside the NBA,” which debuted after TNT acquired NBA rights during the 1989-90 season. He said in June he planned to retire after next season as a broadcaster.
    “I ain’t going nowhere other than TNT,” Barkley said on June 14. “But I have made the decision myself that, no matter what happens, next year is going to be my last year on television.”
    Barkley seemed to waver on his decision to retire during a recent appearance on “The Dan Patrick Show” in late July.
    “Everything is on the table,” Barkley said of his future job opportunities.
    Barkley signed a 10-year deal with TNT Sports in 2022 and is entering his 25th year with the company. In May, Barkley said he had an opt-out clause in the contract in case TNT lost NBA rights. That is incorrect, according to a person with knowledge of the contractual language. Barkley said last month his deal is worth $210 million over 10 years.
    Barkley’s commitment to TNT Sports likely closes the door on recreating “Inside the NBA” for another network if Warner Bros. Discovery does not emerge with a package of games as an outcome of its NBA lawsuit.

    Don’t miss these insights from CNBC PRO More

  • in

    Yum Brands reports mixed results as Pizza Hut and KFC same-store sales fall

    Yum Brands reported earnings that topped estimates but revenue that fell short of expectations for the second quarter.
    KFC and Pizza Hut both saw their same-store sales shrink.
    Only Taco Bell, the jewel of the company’s portfolio, reported same-store sales growth.

    A sign is posted in front of a Taco Bell restaurant on May 01, 2024 in Richmond, California. 
    Justin Sullivan | Getty Images

    Yum Brands on Tuesday reported a mixed quarter as both Pizza Hut and KFC reported declining same-store sales.
    Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by LSEG:

    Earnings per share: $1.35 adjusted vs. $1.33 expected
    Revenue: $1.76 billion vs. $1.8 billion expected

    Yum reported second-quarter net income of $367 million, or $1.28 per share, down from $418 million, or $1.46 per share, a year earlier.
    Excluding items, the company earned $1.35 per share.
    Net sales rose 4% to $1.76 billion, fueled by new restaurant openings. Yum’s same-store sales fell 1% in the quarter as both Pizza Hut and KFC reported same-store sales declines of 3%.
    KFC’s U.S. restaurants continued to struggle, with domestic same-store sales shrinking 5%. And although the chicken chain’s system sales picked up this quarter in China, its largest market, KFC’s overall international same-store sales fell 3%.
    Pizza Hut’s U.S. same-store sales decreased 1%, while its international same-store sales declined 4%.

    Taco Bell, the crown jewel of Yum’s portfolio, saw its same-store sales increase 5% in the quarter. The chain’s footprint is largely concentrated in the U.S., where its reputation for value has helped it weather the pullback in consumer spending.
    On Wednesday, Yum announced plans to expand its rollout of artificial intelligence across Taco Bell drive-thru lanes to hundreds of its U.S. restaurants by the end of the year.
    This story is developing. Please check back for updates. More

  • in

    Why Japanese stocks are on a rollercoaster ride

    As fears of an American recession spread, stockmarkets around the world have been jittery. The moves have been the wildest of all in Japan. On August 5th the Topix plunged by 12% in its worst performance since 1987; the yen had climbed from its weakest point in 37 years. The next day, stocks swung back, rising by 9%, as investors snapped up stocks that had plunged in value. The sharp moves carry implications not just for Japanese investors and firms. The country’s financial heft means that they could become a source of further volatility in nervous global markets. More